Hok Hei Tam

Senior Principal

2023 - Current

Principal

2021 - 2023

Senior Associate

2019 - 2021

Co-Founder of Senda Biosciences

Associate

2017 - 2019

Co-Founder of FL62 and FL65.

CTO

2019

Acting CTO

2020 - 2023

Scientific Consultant

2017 - 2017

Bioinformatics Consultant

2017 - 2017

PhD Candidate

2012 - 2017

Ph. D. in Chemical Engineering with a Minor in Machine Learning Advisor: Dr. Daniel Anderson Committee: Dr. Bob Langer and Dr. Angela Koehler At the Anderson Lab, I developed a vaccine dosing scheme that leads to >10-fold improvement in antibody production, leading to a first-author publication in the Proceedings of the National Academy of Science. I also created statistical methods and software to analyze the effects of novel materials on fibrosis, leading to 4 publications in top journals: Nature Medicine, Nature Biotechnology, and Nature Materials. Furthermore, I developed novel conjugates for siRNA delivery to various tumors, leading to a Best Paper in Section award at the largest Chemical Engineering conference (AIChE) and publications in preparation. Work in my Ph.D. has contributed to two venture-backed companies: Sigilon and Verseau Therapeutics.

Entrepreneurial Fellow

2017 - 2017

As an entrepreneurial fellow, I explored new areas of science to generate ideas for first-in-class life-sciences companies.

Project Lead/Developer

2014 - 2017

The PCHR Lebanon project developed a portable patient-centric electronic health record system with decision support features that was deployed to 10 primary healthcare centers throughout Lebanon to assist in the treatment of Syrian refugees with chronic disease. It received a Research for Health in Humanitarian Crises grant from ELRHA. This project was also a finalist in the Applied Innovation Institute's University Mobile Challenge in 2015

Scientific Consultant

2016 - 2017

Scientific Consultant

2016 - 2016